Hara Katsunori, Akahori Masakazu, Tanito Masaki, Kaidzu Sachiko, Ohira Akihiro, Iwata Takeshi
Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, Shimane, Japan.
Mol Vis. 2011;17:3309-13. Epub 2011 Dec 17.
Previous studies have described a possible association between exfoliation syndrome (EX) and various ocular and systemic vascular disorders; however, the association between EX and branch retinal vein occlusion (BRVO) remains unclear. Because slit-lamp examination may overlook latent deposits of exfoliation materials, an ocular biopsy is usually needed for a precise diagnosis. We evaluated a possible association between EX and BRVO using lysyl oxidase-like 1 (LOXL1) gene variants as alternative markers for EX.
Allelic and genotypic frequencies of three LOXL1 variants (rs1048661, rs3825942, and rs2165241) were determined for 78 consecutive Japanese patients with BRVO (11 patients with exfoliation syndrome [EX+], 67 patients without exfoliation syndrome [EX-]), and 158 patients with cataract without EX (CT) as controls.
The rs1048661 variant differed between the BRVO and CT groups in allelic and genotypic frequencies (p=0.0137 and p=0.0203, respectively). Subgroup analysis, compared to the CT group, showed that BRVO EX+ had significantly different allelic and genotypic frequencies of rs1048661 (p=0.00011 and p=0.000189, respectively), while BRVO EX- did not (p=0.175 and p=0.288, respectively). The frequencies of rs3825942 and rs2165241 did not differ between the BRVO and CT groups.
No association was found between BRVO and EX if LOXL1 variants were used as disease markers for clinically undetectable EX. The results suggested that LOXL1 variants, well established markers for EX, are not likely genetic markers for BRVO in Japanese subjects.
以往研究描述了剥脱综合征(EX)与各种眼部及全身血管疾病之间可能存在的关联;然而,EX与视网膜分支静脉阻塞(BRVO)之间的关联仍不明确。由于裂隙灯检查可能会忽略剥脱物质的潜在沉积物,因此通常需要进行眼部活检以做出准确诊断。我们使用赖氨酰氧化酶样1(LOXL1)基因变异作为EX的替代标志物,评估EX与BRVO之间可能存在的关联。
对78例连续的日本BRVO患者(11例患有剥脱综合征[EX+],67例未患有剥脱综合征[EX-])以及158例无EX的白内障患者(CT)作为对照,测定三种LOXL1变异(rs1048661、rs3825942和rs2165241)的等位基因频率和基因型频率。
rs1048661变异在BRVO组和CT组之间的等位基因频率和基因型频率存在差异(分别为p = 0.0137和p = 0.0203)。亚组分析显示,与CT组相比,BRVO EX+的rs1048661等位基因频率和基因型频率有显著差异(分别为p = 0.00011和p = 0.000189),而BRVO EX-则无差异(分别为p = 0.175和p = 0.288)。rs3825942和rs2165241的频率在BRVO组和CT组之间没有差异。
如果将LOXL1变异用作临床不可检测EX的疾病标志物,则未发现BRVO与EX之间存在关联。结果表明,在日本受试者中,作为EX明确标志物的LOXL1变异不太可能是BRVO的遗传标志物。